Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multi-Center, Randomized, Double-Blinded Trial of Percutaneous Tibial Nerve Stimulation With the Bioness StimRouter Neuromodulation System Versus Sham in the Treatment of Overactive Bladder (OAB)

NCT02873312 is registered in ClinicalTrials.gov with Bioness Inc as lead sponsor.

NCT NCT02873312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02873312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multi-Center, Randomized, Double-Blinded Trial of Percutaneous Tibial Nerve Stimulation With the Bioness StimRouter Neuromodulation System Versus Sham in the Treatment of Overactive Bladder (OAB)
Lead sponsor
Bioness Inc
Phase
Not applicable
Overall status
Unknown status
Start date
February 10, 2017
Completion date
July 30, 2021
Enrollment
180 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder